News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tekmira Pharmaceuticals Corporation (TKMR)'s Experimental Ebola Drug May Never Reach Africa


8/14/2014 6:41:34 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A Canadian company investigating an experimental treatment for Ebola may be months away from making new drug supplies, offering no guarantee on Wednesday evening that its unapproved treatment would reach patients.

“The regulatory framework to support its use in Africa has not yet been established,” Tekmira Chief Executive Officer Mark Murray told analysts on an earnings call. “There can be no assurance that an appropriate framework” will be developed.

Vancouver-based Tekmira is one of several companies trying to develop treatments for the deadly virus that has killed more than 1,000 people in West Africa this year, mostly in Guinea, Liberia, and Sierra Leone.
Help employers find you! Check out all the jobs and post your resume.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES